FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Animal Drugs

Canine Idiopathic Epilepsy Drug Approved

FDA gives conditional approval to Pegasus Laboratories KBroVet-CA1 to treat idiopathic epilepsy in dogs.

Human Drugs

Hyperfine Research 510(k) Cleared for Brain Imaging

FDA clears a Hyperfine Research 510(k) for its deep-learning image analysis software to measure brain structure and pathology in images acquired by th...

Medical Devices

FDA View on Paclitaxel-Coated Devices Updated

Three FDA staffers give an update on the agencys position on paclitaxel-coated devices used to treat peripheral arterial disease.

Human Drugs

Pandemic Monoclonal Antibody Potency Assay Guidance

FDA issues an immediately effective guidance to help sponsors develop monoclonal antibodies and other therapeutic proteins for treating Covid-19.

FDA General

FDA 6-Month PREPP Initiative Report

FDA issues a report summarizing its Pandemic Recovery and Preparedness Plan Initiative work in the second half of 2020.

Human Drugs

Several Topics in Ongoing PDUFA Reauthorization Negotiations

FDA releases minutes and meeting summaries for five PDUFA 7 negotiation meetings at the end of 2020.

FDA General

Woodcock Likely Acting Commissioner After Inauguration

Former CDER director Janet Woodcocks recent move to the Office of Commissioner sets in motion her likely elevation to acting commissioner after the pr...

Federal Register

Rule on Fairness in Enforcement Actions

Federal Register notice: HHS issues a final rule to promote transparency and fairness in civil enforcement actions.

Human Drugs

Timber Pharma Wins Orphan Status for Sitaxsentan

FDA grants Timber Pharmaceuticals an orphan drug designation for TMB-003, a locally delivered formulation of sitaxsentan, indicated for treating syste...

Human Drugs

FDA OKs Marinus Ganaxolone NDA Filing

FDA tells Marinus that Marigold study data appear sufficient to justify filing an NDA for oral ganaxolone to treat children and adults with CDKL5 defi...